Enable job alerts via email!
Boost your interview chances
Create a job specific, tailored resume for higher success rate.
Join a dynamic biotech start-up focused on developing innovative therapeutics for neurodegenerative diseases. As the Director/Senior Director of Pharmacology, you will lead small-molecule discovery efforts and collaborate closely with academic and CRO partners. This hybrid role offers a unique opportunity to steer research and drive projects from early discovery to clinical development. Be part of a passionate team backed by leading investors, where your expertise will directly impact the future of neurodegeneration treatments. If you are ready to take on a career-defining role, apply now to make a difference.
Home Jobs Director/Senior Director of Pharmacology (Pharmacology Lead)
24th April 2025
Share
Endlyz Therapeutics, Hybrid (London & Oxford), United Kingdom
EndLyz Therapeutics is a dynamic biotech start-up focused on developing small-molecule disease-modifying therapeutics that restore endo-lysosomal function and abrogate neurodegeneration in Parkinson’s and other dementias. We are seeking a Director/Senior Director of Pharmacology (Pharmacology Lead) to drive our small molecule discovery efforts and help advance our portfolio through early discovery towards clinical development. This hybrid role involves close collaboration with academic and CRO partners with regular presence in both our London and Oxford offices (2 days per week onsite).
The role
You will steer our small-molecule screening activities and conduct research guaranteeing the continuous innovation and timely progress of our portfolio. This is a career-defining opportunity to apply your scientific expertise and lead from the front, reporting directly to the CEO. You will champion our partnership with our network of collaborators and CRO’s to generate data and progress our discovery efforts.
A great opportunity to work at the cutting-edge of neurodegeneration drug discovery, you will be involved in projects from early exploratory through to early clinical development. You will apply your drug discovery and project management skills to support our mission of developing much-needed disease-modifying therapeutics for neurodegenerative diseases.
The ideal candidate will have a strong knowledge of pharmacology, small-molecule screening technologies and a proven record of driving projects forward in a dynamic and collaborative manner, ensuring that our academic and industrial partners deliver to achieve our goals.
Key responsibilities
Skills & experience
About us:
We are developing small-molecule therapeutics targeting ATP13A2 and ATP10B lysosomal transporters. Both targets are critical for maintaining neuronal health, contribute to neurodegeneration and are linked to human diseases. We are a small, fast-moving team of four working in close partnership with a large network of academic collaborators, consultants, contractors and CROs.
We are backed by leading investors including the Dementia Discovery Fund, Oxford Science Enterprises, AbbVie, CD3, and Parkinson’s UK, and are guided by an experienced board and scientific founders. As we prepare for Series A, we’re building a pipeline of first-in-class lysosomal targets with the potential to transform the treatment of neurodegenerative disease. Visit endlyz.com to learn more.
What we can offer:
To Apply
Please apply now with your CV and a tailored covering letter detailing your interest in the role and our company.